Ceapro Inc V.CZO

Chemicals Specialty Chemicals

Ceapro Inc. is a Canada-based biotechnology company. The Company is involved in the development of extraction technology and the application of this technology to the production of extracts and active ingredients from oats and other renewable plant resources. Its primary business activities relate to the development and commercialization of natural products for personal care, cosmetic, human, and animal health industries using technology, natural, renewable resources, and developing products, technologies, and delivery systems. The Company's products include a commercial line of natural active ingredients, including beta glucan, avenanthramides (colloidal oat extract), oat powder, oat oil, oat peptides, and lupin peptides, a commercial line of natural anti-aging skincare products, utilizing active ingredients, including beta glucan and avenanthramides and veterinary therapeutic products, including an oat shampoo, an ear cleanser, and a dermal complex/conditioner.

TSXV:CZO - Post by User

Ceapro Inc > OBG clinical study

<< Previous

Bullboard Posts

Next >>

Comment by Ciaoon Oct 26, 2021 8:35am

78 Views

Post# 34048644

RE:OBG clinical study

Great find!

If the BG pill has a similar effect as Oatwell powder than we could have better than the 12 - 15% LDL reduction reported for the Oatwell study considering;

1) higher dosage
2) longer study period
3) possible synergistic effects with statins
4) broader range of patients with different degrees of hypercholesterolemia

hoffbag wrote: Could be used as a reference for the Ceapro OBG study. Different approach but competitor.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7146517/

<< Previous

Bullboard Posts

Next >>

Soma Gold poised to extend profitable track record